Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01601847 · ClinicalTrials.gov registry record · Phase 4
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
A Phase 4 study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT01601847 is a Phase 4 study that has completed, run by Case Western Reserve University. The registered enrollment target is 300 participants.
The verdict
NCT01601847, a Phase 4 study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
The goal of this study is to identify a vitamin D supplementation strategy that best promotes the lung, immune, and overall health of black infants born preterm (28-36 weeks gestational age). This is a high risk population that seems to have unique vitamin D needs, and inappropriate supplementation may promote wheezing or allergy. The results of this study will help form nutritional recommendations for the approximately 100,000 black infants born at 30-36 weeks gestational age in the U.S. every year.
Interventions
- DIETARY_SUPPLEMENT Cholecalciferol
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-03-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01601847
The ClinicalTrials.gov registry entry for NCT01601847 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cholecalciferol is the first listed.
NCT01601847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01601847 about?
NCT01601847 is a clinical study titled "Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy". The goal of this study is to identify a vitamin D supplementation strategy that best promotes the lung, immune, and overall health of black infants born preterm (28-36 weeks gestational age). This is a high risk population that seems to have unique vitamin D needs, and inappropriate supplementation ...
What is the current status of trial NCT01601847?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2013-01. Estimated completion is 2017-03-12.
What interventions are being tested in trial NCT01601847?
The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT01601847?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.